Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Bénédict Fallet & Ulrich A. Walker. (2020) Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies. Expert Review of Clinical Pharmacology 13:11, pages 1203-1218.
Read now
Read now
Yukinori Endo, Yi Shen, Lamis Abou Youssef, Nishant Mohan & Wen Jin Wu. (2018) T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathways. mAbs 10:7, pages 1003-1017.
Read now
Read now
Ewa Pocheć, Marta Ząbczyńska, Monika Bubka, Joanna Homa & Anna Lityńska. (2016) β1,6-branched complex-type N-glycans affect FAK signaling in metastatic melanoma cells. Cancer Investigation 34:1, pages 45-56.
Read now
Read now
Ke-Fu Yu, Wei-Qiang Zhang, Li-Min Luo, Ping Song, Dan Li, Ruo Du, Wei Ren, Dan Huang, Wan-Liang Lu, Xuan Zhang & Qiang Zhang. (2013) The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation. International Journal of Nanomedicine 8, pages 2473-2485.
Read now
Read now
Javier Margareto, Olatz Leis, Eider Larrarte, Iñigo C. Pomposo, Jesús María Garibi & José Vicente Lafuente. (2009) DNA Copy Number Variation and Gene Expression Analyses Reveal the Implication of Specific Oncogenes and Genes in GBM. Cancer Investigation 27:5, pages 541-548.
Read now
Read now
Articles from other publishers (80)
Robert P. Lyon, Mechthild Jonas, Christopher Frantz, Esther S. Trueblood, Roma Yumul, Lori Westendorf, Christopher J. Hale, Jackie L. Stilwell, Narayana Yeddula, Katie M. Snead, Vineet Kumar, Gabriela I. Patilea-Vrana, Kerry Klussman & Maureen C. Ryan. (2023) SGN-B6A: A New Vedotin Antibody–Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications. Molecular Cancer Therapeutics 22:12, pages 1444-1453.
Crossref
Crossref
Solhwi Lee, Junhui Ma & Se Jin Im. (2023) Expression and function of CD51 on CD8 T cells as an immunomodulatory target. Biochemical and Biophysical Research Communications 661, pages 56-63.
Crossref
Crossref
Junjie Zhang, Xiaodan Su, Lixing Weng, Kaiyuan Tang, Yuchen Miao, Zhaogang Teng & Lianhui Wang. (2023) Gadolinium-hybridized mesoporous organosilica nanoparticles with high magnetic resonance imaging performance for targeted drug delivery. Journal of Colloid and Interface Science 633, pages 102-112.
Crossref
Crossref
Soumyo Sen, Aleksandar Spasic, Anjana Sinha, Jialing Wang, Martin Bush, Jihong Li, Dragana Nešić, Yuchen Zhou, Gabriella Angiulli, Paul Morgan, Leslie Salas-Estrada, Junichi Takagi, Thomas Walz, Barry S. Coller & Marta Filizola. (2022) Structure-Based Discovery of a Novel Class of Small-Molecule Pure Antagonists of Integrin αVβ3. Journal of Chemical Information and Modeling 62:22, pages 5607-5621.
Crossref
Crossref
Otto Luiz Dutra Cerqueira, Mayara Carolline Silva Botelho, Ana Paula Zen Petisco Fiore, Cynthia Aparecida Bueno de Toledo Osório, Rebeka Tomasin, Mauro César Cafundó Morais, Rossana Verónica Mendoza López, Elaine Cristina Cardoso, Santiago Andres Vilella-Arias, Eduardo Moraes Reis & Alexandre Bruni-Cardoso. (2022) Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas. Neoplasia 30, pages 100803.
Crossref
Crossref
Neelu Singh, Priyanka Maurya, Nidhi Mishra, Samipta Singh, Ravi Raj Pal, Priya Singh, Poonam Parashar, Alka Sonkar & Shubhini A. Saraf. 2022. Macrophage Targeted Delivery Systems. Macrophage Targeted Delivery Systems
169
187
.
Nunzianna Doti, Mario Mardirossian, Annamaria Sandomenico, Menotti Ruvo & Andrea Caporale. (2021) Recent Applications of Retro-Inverso Peptides. International Journal of Molecular Sciences 22:16, pages 8677.
Crossref
Crossref
Abhinav Saini, Kumari Binita Chandra, Vikrant Kumar, Sandeep R Mathur, J B Sharma, Sunesh Kumar & Savita Yadav. (2020) Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer. Molecular Biology Reports 47:12, pages 9459-9468.
Crossref
Crossref
Mrinal K. Poddar & Soumyabrata Banerjee. 2020. Platelets. Platelets.
Jihong Li, Yoshiyuki Fukase, Yi Shang, Wei Zou, José M. Muñoz-Félix, Lorena Buitrago, Johannes van Agthoven, Yixiao Zhang, Ryoma Hara, Yuta Tanaka, Rei Okamoto, Takeshi Yasui, Takashi Nakahata, Toshihiro Imaeda, Kazuyoshi Aso, Yuchen Zhou, Charles Locuson, Dragana Nesic, Mark Duggan, Junichi Takagi, Roger D. Vaughan, Thomas Walz, Kairbaan Hodivala-Dilke, Steven L. Teitelbaum, M. Amin Arnaout, Marta Filizola, Michael A. Foley & Barry S. Coller. (2019) Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations. ACS Pharmacology & Translational Science 2:6, pages 387-401.
Crossref
Crossref
Gulnara Tuguzbaeva, Er Yue, Xi Chen, Lina He, Xinlei Li, Jiaming Ju, Ying Qin, Valentin Pavlov, Yanjie Lu, Wenting Jia, Yunlong Bai, Yumei Niu & Baofeng Yang. (2019) PEP06 polypeptide 30 is a novel cluster-dissociating agent inhibiting v integrin/FAK/Src signaling in oral squamous cell carcinoma cells. Acta Pharmaceutica Sinica B 9:6, pages 1163-1173.
Crossref
Crossref
Dinesh Khanna, Donald P Tashkin, Christopher P Denton, Martin W Lubell, Cristina Vazquez-Mateo & Stephen Wax. (2019) Ongoing clinical trials and treatment options for patients with systemic sclerosis–associated interstitial lung disease. Rheumatology 58:4, pages 567-579.
Crossref
Crossref
G. M. Tuguzbaeva & V. N. Pavlov. (2019) The role of integrins αv in the pathogenesis of oral squamous cell carcinoma. Advances in molecular oncology 5:4, pages 86-93.
Crossref
Crossref
Martin Schlesinger. (2018) Role of platelets and platelet receptors in cancer metastasis. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Mati Mann, Arnav Mehta, Carl G. de Boer, Monika S. Kowalczyk, Kevin Lee, Pearce Haldeman, Noga Rogel, Abigail R. Knecht, Daneyal Farouq, Aviv Regev & David Baltimore. (2018) Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory Stimuli Are Altered with Age. Cell Reports 25:11, pages 2992-3005.e5.
Crossref
Crossref
Denise E. Allard, Yan Wang, Jian Joel Li, Bridget Conley, Erin W. Xu, David Sailer, Caellaigh Kimpston, Rebecca Notini, Collin-Jamal Smith, Emel Koseoglu, Joshua Starmer, Xiaopei L. Zeng, James F. HowardJr.Jr., Ahmet Hoke, Steven S. Scherer & Maureen A. Su. (2018) Schwann cell–derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment. Journal of Clinical
Investigation 128:10, pages 4727-4741.
Crossref
Crossref
Bethany A. Kerr & Tatiana V. Byzova. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
2634
2645
.
Zhanpeng LuoDawei LiXiaobo LuoLitao LiSuxi GuLong YuYuanzheng Ma. (2016) Decreased Expression of miR-548c-3p in Osteosarcoma Contributes to Cell Proliferation Via Targeting ITGAV. Cancer Biotherapy and Radiopharmaceuticals 31:5, pages 153-158.
Crossref
Crossref
I-Chun Yeh, Pei-Wen Wang, Hsin-Yi Liu, Ping-Ching Wu, Jenn-Ren Hsiao & Dar-Bin Shieh. (2016) Integrin Targeted Gold Nanoparticles Potentiate Cancer Radiation Sensitivity: Synthesizing and modifying gold nanorods to target cancer cells.. IEEE Nanotechnology Magazine 10:1, pages 4-15.
Crossref
Crossref
Xiao-Ding Xu, Yin-Jia Cheng, Jun Wu, Hong Cheng, Si-Xue Cheng, Ren-Xi Zhuo & Xian-Zheng Zhang. (2016) Smart and hyper-fast responsive polyprodrug nanoplatform for targeted cancer therapy. Biomaterials 76, pages 238-249.
Crossref
Crossref
Maxime Grillaud & Alberto Bianco. (2014) Multifunctional adamantane derivatives as new scaffolds for the multipresentation of bioactive peptides. Journal of Peptide Science 21:5, pages 330-345.
Crossref
Crossref
Kimberley J. Reeves, Jack E. Hurrell, Marco Cecchini, Gabri van der Pluijm, Jenny M. Down, Colby L. Eaton, Freddie Hamdy, Philippe Clement-Lacroix & Nicola J. Brown. (2015)
Prostate cancer cells home to bone using a novel
in vivo
model: Modulation by the integrin antagonist GLPG0187
. International Journal of Cancer 136:7, pages 1731-1740.
Crossref
Crossref
E. Élez, I. Kocáková, T. Höhler, U.M. Martens, C. Bokemeyer, E. Van Cutsem, B. Melichar, M. Smakal, T. Csőszi, E. Topuzov, R. Orlova, S. Tjulandin, F. Rivera, J. Straub, R. Bruns, S. Quaratino & J. Tabernero. (2015) Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial. Annals of Oncology 26:1, pages 132-140.
Crossref
Crossref
Geertje van der Horst, Lieke Bos, Maaike van der Mark, Henry Cheung, Bertrand Heckmann, Philippe Clément-Lacroix, Giocondo Lorenzon, Rob C. M. Pelger, Rob F. M. Bevers & Gabri van der Pluijm. (2014) Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma. PLoS ONE 9:9, pages e108464.
Crossref
Crossref
Yasutaka Hayashido, Hisataka Kitano, Taishi Sakaue, Takahiko� Fujii, Mirei Suematsu, Shigeru Sakurai & Tetsuji Okamoto. (2014) Overexpression of integrin�αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via mek/erk signaling pathway that is activated by interaction of integrin�αvβ8 with type Ⅰ collagen. International Journal of Oncology.
Crossref
Crossref
Lina Y. Hu, Nadine Bauer, Leah M. Knight, Zibo Li, Shuanglong Liu, Carolyn J. Anderson, Peter S. Conti & Julie L. Sutcliffe. (2014) Characterization and Evaluation of 64Cu-Labeled A20FMDV2 Conjugates for Imaging the Integrin αvβ6. Molecular Imaging and Biology 16:4, pages 567-577.
Crossref
Crossref
Nadia Anikeeva, Maria Steblyanko, Svetlana Fayngerts, Natalya Kopylova, Deborah J. Marshall, Gordon D. Powers, Takami Sato, Kerry S. Campbell & Yuri Sykulev. (2014) Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. European Journal of Immunology 44:8, pages 2331-2339.
Crossref
Crossref
Marcelina Elżbieta Janik, Anna Lityńska & Małgorzata Przybyło. (2014) Studies on primary uveal and cutaneous melanoma cell interaction with vitronectin. Cell Biology International 38:8, pages 942-952.
Crossref
Crossref
Sang Yun Ha, Juyoun Shin, Jeong Hoon Kim, Myung Soo Kang, Hae-Yong Yoo, Hyeon-Ho Kim, Sung-Hee Um & Seok-Hyung Kim. (2014) Overexpression of integrin αv correlates with poor prognosis in colorectal cancer. Journal of Clinical Pathology 67:7, pages 576-581.
Crossref
Crossref
Manfred Wirth, Axel Heidenreich, Jürgen E. Gschwend, Thierry Gil, Stefan Zastrow, Michael Laniado, Joachim Gerloff, Michael Zühlsdorf, Giacomo Mordenti, Wolfgang Uhl & Heinrich Lannert. (2014) A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy. European Urology 65:5, pages 897-904.
Crossref
Crossref
Fahmy A. Mamuya, Yan Wang, Victoria H. Roop, David A. Scheiblin, Jocelyn C. Zajac & Melinda K. Duncan. (2014)
The roles of α
V
integrins in lens
EMT
and posterior capsular opacification
. Journal of Cellular and Molecular Medicine 18:4, pages 656-670.
Crossref
Crossref
Wolfgang Uhl, Michael Zühlsdorf, Thomas Koernicke, Ulf Forssmann & Andreas Kovar. (2013) Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses. Investigational New Drugs 32:2, pages 347-354.
Crossref
Crossref
Rachel L. Beingessner, Alaaeddin Alsbaiee, Baljit Singh, Thomas J. Webster & Hicham Fenniri. 2013. Peptide Materials. Peptide Materials
313
357
.
Jingquan Jia, Alex Starodub, Ian Cushman, Yingmiao Liu, Deborah J. Marshall, Herbert I. Hurwitz & Andrew B. Nixon. (2013) Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer. Anti-Cancer Drugs 24:3, pages 237-250.
Crossref
Crossref
Colleen S. Curran & Patricia J. Keely. (2013) Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition. Matrix Biology 32:2, pages 95-105.
Crossref
Crossref
Paul M. Levine, Tom P. Carberry, Justin M. Holub & Kent Kirshenbaum. (2013) Crafting precise multivalent architectures. MedChemComm 4:3, pages 493-509.
Crossref
Crossref
Dana M Roque, Peter E Schwartz & Alessandro D Santin. (2012) Targeted therapy for high-risk endometrial carcinoma. Clinical Practice 9:5, pages 539-554.
Crossref
Crossref
Geertje van der Horst, Lieke Bos & Gabri van der Pluijm. (2012) Epithelial Plasticity, Cancer Stem Cells, and the Tumor-Supportive Stroma in Bladder Carcinoma. Molecular Cancer Research 10:8, pages 995-1009.
Crossref
Crossref
Patrick J. McEnaney, Christopher G. Parker, Andrew X. Zhang & David A. Spiegel. (2012) Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease. ACS Chemical Biology 7:7, pages 1139-1151.
Crossref
Crossref
Ming-Wei Chang, Jem-Mau Lo, Hsueh-Fen Juan, Hsin-Yi Chang & Chun-Yu Chuang. (2012) Combination of RGD Compound and Low-Dose Paclitaxel Induces Apoptosis in Human Glioblastoma Cells. PLoS ONE 7:5, pages e37935.
Crossref
Crossref
Fahmy A. Mamuya & Melinda K. Duncan. (2012) aV integrins and TGF‐β‐induced EMT: a circle of regulation. Journal of Cellular and Molecular Medicine 16:3, pages 445-455.
Crossref
Crossref
Radu Minea, Corey Helchowski, Barbara Rubino, Kyle Brodmann, Stephen Swenson & Francis MarklandJr.Jr.. (2012) Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential. Toxicon 59:4, pages 472-486.
Crossref
Crossref
Cordula Kempkes, Anke Rattenholl, Jörg Buddenkotte, Elwira Strozyk, Jürgen Eberle, Angelika Hausser, Ferda Cevikbas, Stefan W. Schneider & Martin Steinhoff. (2012) Proteinase-Activated Receptors 1 and 2 Regulate Invasive Behavior of Human Melanoma Cells via Activation of Protein Kinase D1. Journal of Investigative Dermatology 132:2, pages 375-384.
Crossref
Crossref
Ethan A. Englund, Deyun Wang, Hidetsugu Fujigaki, Hiroyasu Sakai, Christopher M. Micklitsch, Rodolfo Ghirlando, Gema Martin-Manso, Michael L. Pendrak, David D. Roberts, Stewart R. Durell & Daniel H. Appella. (2012) Programmable multivalent display of receptor ligands using peptide nucleic acid nanoscaffolds. Nature Communications 3:1.
Crossref
Crossref
Sejeong Shin, Laura Wolgamott & Sang-Oh Yoon. (2012) Integrin Trafficking and Tumor Progression. International Journal of Cell Biology 2012, pages 1-7.
Crossref
Crossref
Anke S. Lonsdorf, Björn F. Krämer, Manuela Fahrleitner, Tanja Schönberger, Stephan Gnerlich, Sabine Ring, Sarah Gehring, Stefan W. Schneider, Michael J. Kruhlak, Sven G. Meuth, Bernhard Nieswandt, Meinrad Gawaz, Alexander H. Enk & Harald F. Langer. (2012) Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 Integrin Mediates Interaction of Melanoma Cells with Platelets. Journal of Biological Chemistry 287:3, pages 2168-2178.
Crossref
Crossref
Bethany A. Kerr & Tatiana V. Byzova. 2012. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
949
959
.
Alessandra Tolomelli, Luca Gentilucci, Elisa Mosconi, Angelo Viola, Samantha Deianira Dattoli, Monica Baiula, Santi Spampinato, Laura Belvisi & Monica Civera. (2011) Development of Isoxazoline-Containing Peptidomimetics as Dual αvβ3 and α5β1 Integrin Ligands. ChemMedChem 6:12, pages 2264-2272.
Crossref
Crossref
Christel van den Hoogen, Geertje van der Horst, Henry Cheung, Jeroen T. Buijs, Rob C.M. Pelger & Gabri van der Pluijm. (2011) Integrin αv Expression Is Required for the Acquisition of a Metastatic Stem/Progenitor Cell Phenotype in Human Prostate Cancer. The American Journal of Pathology 179:5, pages 2559-2568.
Crossref
Crossref
Ute Mühlhausen, Dorde Komljenovic, Maren Bretschi, Karin Leotta, Michael Eisenhut, Wolfhard Semmler & Tobias Bäuerle. (2011)
A novel PET tracer for the imaging of
α
v
β
3 and
α
v
β
5 integrins in experimental breast cancer bone metastases
. Contrast Media & Molecular Imaging 6:6, pages 413-420.
Crossref
Crossref
Marta Bellone, Emiliano Cocco, Joyce Varughese, Stefania Bellone, Paola Todeschini, Karim El-Sahwi, Luisa Carrara, Federica Guzzo, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Deborah J. Marshall & Alessandro D. Santin. (2011) Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody. International Journal of Gynecological Cancer 21:6, pages 1084-1090.
Crossref
Crossref
Adam Hsu, Bita Esmaeli, Brent Hayek, Mohammad G. Hossain, Roman Shinder, Alexander J. Lazar & Joseph H. McCarty. (2011) Analysis of αv integrin protein expression in human eyelid and periorbital squamous cell carcinomas. Journal of Cutaneous Pathology 38:7, pages 570-575.
Crossref
Crossref
Takeo Ito, Masaki Inoue, Kanako Akamatsu, Eriko Kusaka, Kazuhito Tanabe & Sei-ichi Nishimoto. (2011) αvβ3-Integrin-targeting lanthanide complex: Synthesis and evaluation as a tumor-homing luminescent probe. Bioorganic & Medicinal Chemistry Letters 21:12, pages 3515-3518.
Crossref
Crossref
Tobias Bäuerle, Dorde Komljenovic, Maximilian Merz, Martin R. Berger, Simon L. Goodman & Wolfhard Semmler. (2010)
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE‐MRI in a longitudinal
in vivo
study
. International Journal of Cancer 128:10, pages 2453-2462.
Crossref
Crossref
Ruth A. Ross. (2011) L-α-Lysophosphatidylinositol meets GPR55: a deadly relationship. Trends in Pharmacological Sciences 32:5, pages 265-269.
Crossref
Crossref
Siamack Sabrkhany, Arjan W. Griffioen & Mirjam G.A. oude Egbrink. (2011) The role of blood platelets in tumor angiogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1815:2, pages 189-196.
Crossref
Crossref
Sandra Schordan, Eric Schordan, Karlhans Endlich & Nicole Endlich. (2011)
α
V
-Integrins mediate the mechanoprotective action of osteopontin in podocytes
. American Journal of Physiology-Renal Physiology 300:1, pages F119-F132.
Crossref
Crossref
Jochen G. Schneider, Sarah R. Amend & Katherine N. Weilbaecher. (2011) Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions. Bone 48:1, pages 54-65.
Crossref
Crossref
Daniel L. Worthley, Andrew S. Giraud & Timothy C. Wang. (2010) The Extracellular Matrix in Digestive Cancer. Cancer Microenvironment 3:1, pages 177-185.
Crossref
Crossref
Holger Kubas, Martin Schäfer, Ulrike Bauder-Wüst, Matthias Eder, Dörte Oltmanns, Uwe Haberkorn, Walter Mier & Michael Eisenhut. (2010) Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding. Nuclear Medicine and Biology 37:8, pages 885-891.
Crossref
Crossref
Ararat J. AbloogluEugene TkachenkoJian KangSanford J. Shattil. (2010) Integrin αV is necessary for gastrulation movements that regulate vertebrate body asymmetry. Development 137:20, pages 3449-3458.
Crossref
Crossref
Dermot Cox, Marian Brennan & Niamh Moran. (2010) Integrins as therapeutic targets: lessons and opportunities. Nature Reviews Drug Discovery 9:10, pages 804-820.
Crossref
Crossref
Radu O. Minea, Corey M. Helchowski, Samuel J. Zidovetzki, Fritz K. Costa, Stephen D. Swenson & Francis S. Markland. (2010) Vicrostatin – An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities. PLoS ONE 5:6, pages e10929.
Crossref
Crossref
Bethany Kerr & Tatiana Byzova. (2010) Integrin alpha V. AfCS-Nature Molecule Pages.
Crossref
Crossref
Zhuoshun Yang, Zhang Lei, Bo Li, Yu Zhou, Gui-Mei Zhang, Zuo-Hua Feng, Biao Zhang, Guan-Xin Shen & Bo Huang. (2010) Rapamycin inhibits lung metastasis of B16 melanoma cells through down-regulating alphav integrin expression and up-regulating apoptosis signaling. Cancer Science 101:2, pages 494-500.
Crossref
Crossref
LENA J. GAMBLE, ANTON V. BOROVJAGIN & QIANA L. MATTHEWS. (2010) Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy. Experimental and Therapeutic Medicine 1:2, pages 233-240.
Crossref
Crossref
Y. Bechah, C. Capo, G. Grau, D. Raoult & J.-L. Mege. (2009) Rickettsia prowazekii infection of endothelial cells increases leukocyte adhesion through αvβ3 integrin engagement. Clinical Microbiology and Infection 15, pages 249-250.
Crossref
Crossref
Liangru Contois, Abebe Akalu & Peter C. Brooks. (2009) Integrins as “functional hubs” in the regulation of pathological angiogenesis. Seminars in Cancer Biology 19:5, pages 318-328.
Crossref
Crossref
Masanao Murakami, Rajeev Kaul, Pankaj Kumar & Erle S. Robertson. (2009) Nucleoside diphosphate kinase/Nm23 and Epstein–Barr virus. Molecular and Cellular Biochemistry 329:1-2, pages 131-139.
Crossref
Crossref
Célia R.C. FrancoEdvaldo S. TrindadeHugo A.O. RochaRafael Bertoni da SilveiraKatia Sabrina PaludoRoger ChammasSilvio S. VeigaHelena B. NaderCarl P. Dietrich. (2009)
Glycosaminoglycan chains from α
5
β
1
integrin are involved in fibronectin-dependent cell migrationDedicated to the memory of Professor Carl P. Dietrich.
. Biochemistry and Cell Biology 87:4, pages 677-686.
Crossref
Crossref
Sven H. Hausner, Craig K. Abbey, Richard J. Bold, M. Karen Gagnon, Jan Marik, John F. Marshall, Cathy E. Stanecki & Julie L. Sutcliffe. (2009)
Targeted
In vivo
Imaging of Integrin αvβ6 with an Improved Radiotracer and Its Relevance in a Pancreatic Tumor Model
. Cancer Research 69:14, pages 5843-5850.
Crossref
Crossref
Sarabjeet S. Suri, Felaniaina Rakotondradany, Andrew J. Myles, Hicham Fenniri & Baljit Singh. (2009) The role of RGD-tagged helical rosette nanotubes in the induction of inflammation and apoptosis in human lung adenocarcinoma cells through the P38 MAPK pathway. Biomaterials 30:17, pages 3084-3090.
Crossref
Crossref
Konstantinos A. Paschos, David Canovas & Nigel C. Bird. (2009) The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cellular Signalling 21:5, pages 665-674.
Crossref
Crossref
T. Bureyko, H. Hurdle, J. B. Metcalfe, M. T. Clandinin & Vera C. Mazurak. (2008)
Reduced growth and integrin expression of prostate cells cultured with lycopene, vitamin E and fish oil
in vitro
. British Journal of Nutrition 101:7, pages 990-997.
Crossref
Crossref
Mikhail Popkov, Beatriz Gonzalez, Subhash C. Sinha & Carlos F. BarbasIIIIII. (2009) Instant immunity through chemically programmable vaccination and covalent self-assembly. Proceedings of the National Academy of Sciences 106:11, pages 4378-4383.
Crossref
Crossref
Aws Alshamsan, Azita Haddadi, Vanessa Incani, John Samuel, Afsaneh Lavasanifar & Hasan Uludağ. (2008) Formulation and Delivery of siRNA by Oleic Acid and Stearic Acid Modified Polyethylenimine. Molecular Pharmaceutics 6:1, pages 121-133.
Crossref
Crossref
Robert O. Dillman. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy
303
406
.
Mitra AhmadiLucie SanceyArnaud BriatLaurent RiouDidier BoturynPascal DumyDaniel FagretCatherine GhezziJean-Philippe Vuillez. (2008)
Chemical and Biological Evaluations of an
111
In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model
. Cancer Biotherapy and Radiopharmaceuticals 23:6, pages 691-700.
Crossref
Crossref
Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, Beatrice Nico, Domenico Ribatti, Antonio Daga, Gabriella Baio, Carlo E. Neumaier, Chiara Brignole, Monica Loi, Danilo Marimpietri, Gabriella Pagnan, Michele Cilli, Eugene A. Lepekhin, Seema V. Garde, Renato Longhi, Angelo Corti, Theresa M. Allen, Jinzi J. Wu & Mirco Ponzoni. (2008) Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin. Clinical Cancer Research 14:22, pages 7320-7329.
Crossref
Crossref
Joseph H. McCarty. (2008) αv Integrins Lead the Way for Colorectal Metastases. Clinical Cancer Research 14:20, pages 6351-6353.
Crossref
Crossref